A single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping, and multiple gene analyses in the majority of non-small cell lung cancer cases

Human Pathology

Volumn 51, Issue , 2016, Pages 139-145

  Rooper, Lisa M ^a   Nikolskaia, Olga ^a   Carter, Jamal ^a   Ning, Yi ^a   Lin, Ming Tseh ^a   Maleki, Zahra ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adequacy; Cytology; EBUS TBNA; Immunohistochemistry; Molecular diagnostics; Non small cell lung cancer

Indexed keywords

ALK PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; ENDOBRONCHIAL ULTRASONOGRAPHY; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSTICS; NEXT GENERATION SEQUENCING; NON SMALL CELL LUNG CANCER; TRANSBRONCHIAL ASPIRATION; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; FINE NEEDLE ASPIRATION BIOPSY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENETICS; INTERVENTIONAL ULTRASONOGRAPHY; LUNG NEOPLASMS; MICRODISSECTION; MIDDLE AGED; NEEDLE BIOPSY; POLYMERASE CHAIN REACTION; PROCEDURES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; BIOPSY, NEEDLE; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MICRODISSECTION; MIDDLE AGED; POLYMERASE CHAIN REACTION; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84961139439     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2015.12.025     Document Type: Article

References (34)

1. F.A. Shepherd, J. Rodrigues Pereira, T. Ciuleanu, and et al. Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 2005 123 132
2. N. Thatcher, A. Chang, P. Parikh, and et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) Lancet 366 2005 1527 1537
3. E.L. Kwak, Y.J. Bang, D.R. Camidge, and et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer N Engl J Med 363 2010 1693 1703
4. G. Scagliotti, N. Hanna, F. Fossella, and et al. The differential efficacy of pemetrexed according to NSCLC histology: A review of two Phase III studies Oncologist 14 2009 253 263
5. D.H. Johnson, L. Fehrenbacher, W.F. Novotny, and et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer J Clin Oncol 22 2004 2184 2191
6. W.D. Travis, E. Brambilla, M. Noguchi, and et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma J Thorac Oncol 6 2011 244 285
7. W.D. Travis, E. Brambilla, M. Noguchi, and et al. Diagnosis of lung cancer in small biopsies and cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification Arch Pathol Lab Med 137 2013 668 684
8. G. da Cunha Santos, S.W. Lai, M.A. Saieg, and et al. Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: Review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype Lung Cancer 77 2012 501 506
9. T. Nakajima, K. Yasufuku, M. Nakajima, and et al. Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment J Thorac Oncol 5 2010 606 611
10. N. Rekhtman, S.M. Brandt, C.S. Sigel, and et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: High accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing J Thorac Oncol 6 2011 451 458
11. J.T. Annema, J.P. van Meerbeeck, R.C. Rintoul, and et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: A randomized trial JAMA 304 2010 2245 2252
12. Z.S. DePew, E.S. Edell, D.E. Midthun, and et al. Endobronchial ultrasound-guided transbronchial needle aspiration: Determinants of sampling adequacy J Bronchol Interv Pulmonol 19 2012 271 276
13. F.J. Herth Nonsurgical staging of the mediastinum: EBUS and EUS Semin Respir Crit Care Med 32 2011 62 68
14. A. Karunamurthy, G. Cai, S. Dacic, W.E. Khalbuss, L. Pantanowitz, and S.E. Monaco Evaluation of endobronchial ultrasound-guided fine-needle aspirations (EBUS-FNA): Correlation with adequacy and histologic follow-up Cancer Cytopathol 122 2014 23 32
15. N. Navani, J.M. Brown, M. Nankivell, and et al. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: A multicenter study of 774 patients Am J Respir Crit Care Med 185 2012 1316 1322
16. L.M. Stoll, R.C. Yung, D.P. Clark, and Q.K. Li Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration Cancer Cytopathol 118 2010 278 286
17. J. Vansteenkiste, C. Dooms, and P. De Leyn The multidisciplinarity of stage III non-small cell lung cancer Eur J Cancer 45 Suppl. 1 2009 92 105
18. E. Folch, N. Yamaguchi, P.A. VanderLaan, and et al. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in non-small-cell lung cancer J Thorac Oncol 8 2013 1438 1444
19. D.P. Steinfort, D. Liew, M. Conron, A.F. Hutchinson, and L.B. Irving Cost-benefit of minimally invasive staging of non-small cell lung cancer: A decision tree sensitivity analysis J Thorac Oncol 5 2010 1564 1570
20. G. Esterbrook, S. Anathhanam, and P.K. Plant Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer Lung Cancer 80 2013 30 34
21. S. Billah, J. Stewart, G. Staerkel, S. Chen, Y. Gong, and M. Guo EGFR and KRAS mutations in lung carcinoma: Molecular testing by using cytology specimens Cancer Cytopathol 119 2011 111 117
22. I. Garcia-Olive, E. Monso, F. Andreo, and et al. Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations Eur Respir J 35 2010 391 395
23. J. Sanz-Santos, P. Serra, F. Andreo, M. Llatjos, E. Castella, and E. Monso Contribution of cell blocks obtained through endobronchial ultrasound-guided transbronchial needle aspiration to the diagnosis of lung cancer BMC Cancer 12 2012 34
24. O.C.J. Schuurbiers, M.G. Looijen-Salamon, M.J.L. Ligtenberg, and H.F.M. van der Heijden A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- A nd endobronchial ultrasound- guided fine needle cytological aspirates J Thorac Oncol 5 2010 1664 1667
25. W.D. Travis, and N. Rekhtman Pathological diagnosis and classification of lung cancer in small biopsies and cytology: Strategic management of tissue for molecular testing Semin Respir Crit Care Med 32 2011 22 31
26. D. Feller-Kopman, R.C. Yung, F. Burroughs, and Q.K. Li Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: A retrospective study with histology correlation Cancer 117 2009 482 490
27. L. Yarmus, J. Akulian, C. Gilbert, and et al. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Ann Am Thorac Soc 10 2013 636 643
28. M.T. Lin, L.H. Tseng, K. Beierl, and et al. Analysis of hematopoietic stem cell transplant engraftment: Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy Diagn Mol Pathol 20 2011 194 202
29. M.T. Lin, S.L. Mosier, M. Thiess, and et al. Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing Am J Clin Pathol 141 2014 856 866
30. L. Sakr, P. Roll, M.J. Payan, and et al. Cytology-based treatment decision in primary lung cancer: Is it accurate enough? Lung Cancer 75 2012 293 299
31. E. Thunnissen, K.M. Kerr, F.J. Herth, and et al. The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group Lung Cancer 76 2012 1 18
32. W. Sterlacci, S. Savic, T. Schmid, and et al. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact Am J Clin Pathol 137 2012 946 956
33. J. Terry, S. Leung, J. Laskin, K.O. Leslie, A.M. Gown, and D.N. Ionescu Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples Am J Surg Pathol 34 2010 1805 1811
34. D.E. Ost, A. Ernst, X. Lei, and et al. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration: Results of the AQuIRE Bronchoscopy Registry Chest 140 2011 1557 1566